At this time, posts about Hyundai Pharm are rapidly increasing on portals and stock communities. Today, foreigners have net sold 34,000 shares of Hyundai Pharm, and institutions have net sold 31,000 shares, according to provisional data. Hyundai Pharm is known as a manufacturer of health beverages such as Miero Fiber and pharmaceuticals.


As of 11:30 AM on the 8th, Hyundai Pharm's stock price is 7,110 KRW, up 8.05% from the previous day, with a trading volume of 15,528,072 shares, which is 278.76% of the 5-day average trading volume. On October 6th, Hyundai Pharm became a market issue with a 7% rise, noted as "Attention on 'Povidone-related stocks'.


In addition to Hyundai Pharm, posts from investors are also rapidly increasing for Humax (115160), Nara M&D (051490), and Boryung Pharmaceutical (003850).



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing